Cardiovascular And Electrophysiology Pipeline Will Unlock Future Markets

AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Published
02 Sep 24
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
US$140.88
23.5% undervalued intrinsic discount
31 Jul
US$107.72
Loading
1Y
-4.2%
7D
-1.4%

Author's Valuation

US$140.9

23.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on31 Jul 25

With no significant changes in either the Future P/E ratio or the discount rate, Integer Holdings' consensus analyst price target remains effectively unchanged at $140.88. What's in the News Integer Holdings was dropped from multiple Russell Value indices, including the 2000, 2500, 3000, 3000E, and Small Cap Comp Value benchmarks and indices.

Shared on08 May 25
Fair value Decreased 3.73%

Shared on30 Apr 25
Fair value Increased 9.26%

AnalystConsensusTarget has increased profit margin from 10.2% to 13.3% and decreased future PE multiple from 29.5x to 24.9x.

Shared on23 Apr 25
Fair value Decreased 11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 4.06%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.45%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 2.85%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 1.82%

AnalystConsensusTarget has increased revenue growth from 6.3% to 7.7% and decreased profit margin from 10.7% to 9.4%.